ADVANCE update: TAF/FTC + DTG regimen comparable to SoC for HIV-1 viral suppression
27 Aug 2020
byRoshini Claire Anthony
HIV-1 RNA viral suppression is comparable between tenofovir alafenamide (TAF)/emtricitabine (FTC) + dolutegravir (DTG), tenofovir disoproxil fumarate (TDF)/FTC + DTG, and TDF/FTC/efavirenz (EFV) regimens, according to updated results of the ADVANCE trial.